Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock Team
CASHMERE
1 other identifier
observational
250
1 country
1
Brief Summary
In this before-after monocenter study, the authors teste the hypothesis that the implementation of a dedicated shock team could improve the outcome of patients with refractory cardiogenic shock assisted by mechanical circulatory support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2022
CompletedApril 10, 2023
March 1, 2022
1 year
December 8, 2021
April 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vital status
Proportion of patients alive
One year after short term mechanical circulatory support initiation
Secondary Outcomes (19)
Vital status
30 days after short term mechanical circulatory support initiation
Vital status
3 months after short term mechanical circulatory support initiation
Vital status
6 months after short term mechanical circulatory support initiation
Lenght of stay
up to Intensive Care Unit discharge, an average of 15 days
Lenght of stay
up to one year
- +14 more secondary outcomes
Study Arms (2)
Without Shock Team
Before January 2013, patients with refractory cardiogenic shock were implanted with short term mechanical circulatory device without involvment of a dedicated shock team
With Shock Team
After April 2013, patients with refractory cardiogenic shock were implanted with short term mechanical circulatory device following a collegial meeting of a shock team (cardiac surgeon, cardiologist, intensivist) using a common algorythm.
Interventions
Eligibility Criteria
Consecutive patients with refractory cardiogenic shock treated with short term mechanical circulatory support between January 2007 to April 2019. A two months wash out period following shock team initiation (February and March 2013) has been set.
You may qualify if:
- Diagnosis of cardiogenic shock
- \>1 sign of refractory cardiogenic shock : Dobutamine \>10µg/kg/mn, epinephrine\>0.25µg/kg/mn or Milrinone \> 0.5µg/kg/mn ; ScvO2\<55% ; pO2/FiO2\<100
- No major counter indication to short term mechanical circulatory support : SOFA score \> 15, prolonged cardiac arrest, severe chronic disease, direct LVAD implantation or heart transplantation, counter indication for systemic anticoagulation
You may not qualify if:
- Age \< 18years
- Post cardiotomy cardiogenic shock
- Implantation of Impella 2.5 alone
- Implantation of Intra Aortic Balloon Pump alone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bordeaux University Hospital
Pessac, 33604, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Ouattara, MD, PhD
University Hospital, Bordeaux
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
December 8, 2021
First Posted
April 4, 2022
Study Start
April 1, 2021
Primary Completion
April 1, 2022
Study Completion
April 15, 2022
Last Updated
April 10, 2023
Record last verified: 2022-03